The future research issues are the predictive role of tacrolimus and mTOR inhibitor combination therapy in the development of PTDM and lipid profile components as predictors of PTDM and prospective exploration of ≥1 accurate definitions of transient posttransplantation hyperglycemia in the prediction of PTDM. The gene discussed is MTOR; the disease is Hyperglycemia.